🔎 Trials Near Me

Akèy › Kansè ovè › Texas › Tyler

Etid klinik pou Kansè ovè nan Tyler, TX

7 etid pou Kansè ovè ap chèche patisipan nan sit nan ak bò kote Tyler (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Ap rekriteFaz 2
  • Site 0203 - Texas Oncology, Tyler
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05128825

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

Ap rekriteFaz 2
  • Texas Oncology - Northeast Texas /ID# 277737, Tyler
Laj 18 ak plis · Fanm · Mizajou Sep 22, 2026 · NCT07059845

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Ap rekriteFaz 2
  • Texas Oncology-Tyler, Tyler
Laj 18 a 99 · Fanm · Mizajou Sep 15, 2026 · NCT07023627

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • Texas Oncology - Northeast TX, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • UT Health East Texas HOPE Cancer Center, Tyler
  • UT Health East Texas Hope Cancer Center, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Ap rekriteFaz 1
  • Sarah Cannon Research Institute Texas Oncology, Tyler
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05103683

Etid Kansè ovè nan lòt vil

Lòt etid nan Tyler

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.